These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31760494)

  • 1. Evidence for and Against ACC/AHA 2017 Guideline for Target Systolic Blood Pressure of < 130 mmHg in Persons with Type 2 Diabetes.
    Shen JI; Nicholas SB; Williams S; Norris KC
    Curr Cardiol Rep; 2019 Nov; 21(11):149. PubMed ID: 31760494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
    Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
    Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal blood pressure target in diabetes mellitus: a quest coming to an end?
    Papadopoulou E; Angeloudi E; Karras S; Sarafidis P
    J Hum Hypertens; 2018 Oct; 32(10):641-650. PubMed ID: 29934621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.
    Sarafidis PA; Lazaridis AA; Ruiz-Hurtado G; Ruilope LM
    Nat Rev Endocrinol; 2017 Jun; 13(6):365-374. PubMed ID: 28106149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
    Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
    BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting blood pressure in people with diabetes mellitus.
    Brimble KS
    Pol Arch Med Wewn; 2016 Jun; 126(6):411-8. PubMed ID: 27362394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
    Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
    Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intensive blood pressure lowering in patients with diabetes: A pooled analysis of the STEP and ACCORD-BP randomized trials.
    Yang R; Bai J; Fang Z; Wang Y; Feng Y; Liu Y; Chi H; Deng Y; Song Q; Cai J
    Diabetes Obes Metab; 2023 Mar; 25(3):796-804. PubMed ID: 36433919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results.
    Huang C; Dhruva SS; Coppi AC; Warner F; Li SX; Lin H; Nasir K; Krumholz HM
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29133522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials.
    Liu J; Pong A; Gallo S; Darekar A; Terra SG
    Cardiovasc Diabetol; 2019 May; 18(1):59. PubMed ID: 31064361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease.
    Shen Y; Dai Y; Wang XQ; Zhang RY; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2019 Nov; 18(1):160. PubMed ID: 31733658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure targets for hypertension in people with diabetes mellitus.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008277. PubMed ID: 24170669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
    Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J; Gren LH; Zamanian S; Cushman WC;
    J Hypertens; 2020 Aug; 38(8):1567-1577. PubMed ID: 32371767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.